CSat Investment Advisory, L.P. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
CSat Investment Advisory, L.P. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2020$32,000
+10.3%
370
+14.9%
0.00%
-25.0%
Q2 2020$29,000
+163.6%
322
+187.5%
0.00%
+100.0%
Q1 2020$11,000
+10.0%
112
+25.8%
0.00%
-33.3%
Q4 2019$10,000
-94.6%
89
-93.9%
0.00%
-94.8%
Q3 2019$184,000
+28.7%
1,457
+22.6%
0.06%
+13.7%
Q2 2019$143,0001,1880.05%
Other shareholders
HAEMONETICS CORP shareholders Q3 2019
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders